A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.4 EUR -2.44% Market Closed
Market Cap: 6.3m EUR
Have any thoughts about
Acticor Biotech SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Acticor Biotech SA

Current Assets 9.3m
Cash & Short-Term Investments 3.9m
Receivables 4.4m
Other Current Assets 986k
Non-Current Assets 461k
Long-Term Investments 353k
PP&E 22k
Other Non-Current Assets 86k
Current Liabilities 9.4m
Accounts Payable 7.9m
Other Current Liabilities 1.5m
Non-Current Liabilities 5.6m
Long-Term Debt 5.2m
Other Non-Current Liabilities 419k

Balance Sheet
Acticor Biotech SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
3
2
3
2
1
13
8
11
7
4
Cash
3
2
3
2
1
13
8
11
7
4
Short-Term Investments
6
2
0
0
0
0
0
0
0
0
Total Receivables
7
9
7
4
2
1
2
4
5
4
Accounts Receivables
5
6
6
3
1
1
1
1
1
1
Other Receivables
2
3
1
1
1
1
1
4
4
4
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
1
1
0
0
1
1
0
1
Total Current Assets
17
13
12
7
4
14
10
17
12
9
PP&E Net
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
Intangible Assets
9
11
8
6
3
1
1
1
1
0
Goodwill
5
5
9
2
1
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
5
5
9
2
1
0
0
0
0
0
Total Assets
31
N/A
30
-4%
29
-5%
16
-45%
9
-45%
15
+80%
11
-28%
18
+62%
13
-28%
10
-25%
Liabilities
Accounts Payable
6
6
6
5
4
2
3
3
5
8
Accrued Liabilities
2
2
2
1
1
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
1
1
0
0
0
0
1
1
1
Other Current Liabilities
0
0
0
0
0
3
3
1
1
1
Total Current Liabilities
9
9
9
6
5
5
6
4
7
9
Long-Term Debt
4
4
3
3
3
1
2
2
7
5
Minority Interest
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
1
1
1
0
Total Liabilities
13
N/A
13
+0%
12
-8%
9
-21%
8
-14%
6
-21%
9
+46%
7
-26%
15
+121%
15
-1%
Equity
Common Stock
1
1
1
1
1
0
0
1
1
1
Retained Earnings
5
4
3
7
13
19
10
13
26
43
Additional Paid In Capital
13
13
13
13
13
27
12
23
23
37
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
18
N/A
17
-7%
17
-3%
6
-62%
0
-93%
9
+1 826%
2
-81%
11
+542%
2
N/A
5
-137%
Total Liabilities & Equity
31
N/A
30
-4%
29
-5%
16
-45%
9
-45%
15
+80%
11
-28%
18
+62%
13
-28%
10
-25%
Shares Outstanding
Common Shares Outstanding
3
3
3
3
3
11
11
11
11
13

See Also

Discover More